Novo Holdings Leads USD50m Investment in India’s MedGenome with LeapFrog and Sofina
Source(s): LeapFrog Investments
Novo Holdings led a USD50m investment in US-based, India-founded genetic testing company MedGenome, acquiring a minority stake, with follow-on from LeapFrog Investments and Sofina. LeapFrog led a USD55m investment round in April 2020. Read more